SMTL ID : 5w5o.6 (7 other biounits)

Identification of potent and selective RIPK2 inhibitors for the treatment of inflammatory diseases.

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.89 Å

Oligo State

homo-dimer

Ligands

2 x 9XA: 4-{6-(tert-butylsulfonyl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]imidazo[1,2-a]pyridin-3-yl}-6-chloropyridin-2-amine(Non-covalent)

9XA.1: 17 residues within 4Å: Chain A: L.23, S.24, V.31, A.44, K.46, L.78, T.94, E.95, Y.96, M.97, P.98, G.100, S.101, E.104, L.152, A.162, D.163 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:V.31, A:A.44, A:L.78, A:Y.96, A:L.152 Hydrogen bonds: A:K.46, A:M.97, A:D.163 Salt bridges: A:E.104, A:E.104 9XA.2: 18 residues within 4Å: Chain B: L.23, S.24, V.31, A.44, K.46, L.78, I.92, T.94, E.95, Y.96, M.97, P.98, G.100, S.101, E.104, L.152, A.162, D.163 9 PLIP interactions: 9 interactions with chain B Hydrophobic interactions: B:V.31, B:L.78, B:Y.96, B:L.152 Hydrogen bonds: B:K.46, B:M.97, B:D.163, B:D.163 Salt bridges: B:E.104

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

He, X. et al., Identification of Potent and Selective RIPK2 Inhibitors for the Treatment of Inflammatory Diseases. ACS Med Chem Lett (2017)

Release Date

2017-10-25

Peptides

Receptor-interacting serine/threonine-protein kinase 2: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
K

B
L

Receptor-interacting serine/threonine-protein kinase 2

Related Entries With Identical Sequence